Metabolic syndrome and endometrial carcinoma (Q43134857)

14 November 2017

Metabolic syndrome and endometrial carcinoma (English)

1 reference

14 November 2017

1 reference

11

Göran Hallmans

1 reference

14 November 2017

3

Annekatrin Lukanova

1 reference

14 November 2017

1

Tone Bjørge

1 reference

14 November 2017

14

Anders Engeland

1 reference

14 November 2017

4

Steinar Tretli

1 reference

14 November 2017

13

Pär Stattin

1 reference

14 November 2017

7

Kilian Rapp

1 reference

14 November 2017

2

Tanja Stocks

1 reference

14 November 2017

6

Jonas Manjer

1 reference

14 November 2017

8

Hanno Ulmer

1 reference

14 November 2017

10

Hans Concin

1 reference

14 November 2017

5

Randi Selmer

1 reference

14 November 2017

12

Håkan Jonsson

1 reference

14 November 2017

9

Martin Almquist

1 reference

PubMed ID

20219764

14 November 2017

language of work or name

English

0 references

publication date

10 March 2010

1 reference

American Journal of Epidemiology

14 November 2017

1 reference

14 November 2017

171

1 reference

14 November 2017

892-902

1 reference

14 November 2017

8

1 reference

The metabolic syndrome: a concept hard to define

14 November 2017

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Prevalence of the metabolic syndrome and its relation to all-cause and cardiovascular mortality in nondiabetic European men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Components of the metabolic syndrome and colorectal cancer risk; a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

On the use of a continuous metabolic syndrome score in pediatric research

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Does the association of habitual physical activity with the metabolic syndrome differ by level of cardiorespiratory fitness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

The metabolic syndrome: A high-risk state for cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Metabolic abnormalities and risk for colorectal cancer in the physicians' health study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Body size in relation to cancer of the uterine corpus in 1 million Norwegian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Overweight as an avoidable cause of cancer in Europe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Metabolic abnormalities (hypertension, hyperglycemia and overweight), lifestyle (high energy intake and physical inactivity) and endometrial cancer risk in a Norwegian cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Body size in different periods of life, diabetes mellitus, hypertension, and risk of postmenopausal endometrial cancer (Sweden).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Body mass, diabetes and smoking, and endometrial cancer risk: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Cohort profile: cohort of Norway (CONOR)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Non-fasting serum triglyceride concentration and mortality from coronary heart disease and any cause in middle aged Norwegian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

The completeness of the Swedish Cancer Register: a sample survey for year 1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Metabolic syndrome--what is the clinical usefulness?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Hysterectomy on benign indications in Sweden 1987-2003: a nationwide trend analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Hysterectomy rates in the United States, 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Time-dependent association of total serum cholesterol and cancer incidence in a cohort of 172,210 men and women: a prospective 19-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Oncogenic alterations of metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

On the Origin of Cancer Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

P-LAP/IRAP-induced cell proliferation and glucose uptake in endometrial carcinoma cells via insulin receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Role of oxygen radicals in DNA damage and cancer incidence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Diet-derived advanced glycation end products are major contributors to the body's AGE pool and induce inflammation in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Diabetes and advanced glycation endproducts

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Cancer and hypertension: a potential for crosstalk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

Hypertension and Hormone-Related Neoplasms in Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FAJE%2FKWQ006

21 January 2018

Identifiers

DOI

10.1093/AJE/KWQ006

1 reference

14 November 2017

1 reference

PubMed ID

20219764